*Result*: Quantum denoising autoencoder improves retinal fundus image quality for early diabetic retinopathy screening.

Title:
Quantum denoising autoencoder improves retinal fundus image quality for early diabetic retinopathy screening.
Authors:
Chilukuri R; School of Computer Science & Artificial Intelligence, SR University, Warangal, Telangana, 506371, India., P P; School of Computer Science & Artificial Intelligence, SR University, Warangal, Telangana, 506371, India. prawin1731@gmail.com., Gatla RK; Department of Computer Science and Engineering (Data Science), Institute of Aeronautical Engineering, Hyderabad, Telangana, 500043, India., Almenweer RA; Faculty of Mechanical and Electrical Engineering, Damascus University, Damascus, Syrian Arab Republic. reem.almenweer@damascusuniversity.edu.sy.
Source:
Scientific reports [Sci Rep] 2026 Jan 21; Vol. 16 (1), pp. 5970. Date of Electronic Publication: 2026 Jan 21.
Publication Type:
Journal Article
Language:
English
Journal Info:
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Imprint Name(s):
Original Publication: London : Nature Publishing Group, copyright 2011-
References:
Sensors (Basel). 2019 Sep 03;19(17):. (PMID: 31484432)
Biosens Bioelectron. 2025 Jul 01;279:117408. (PMID: 40147085)
Comput Methods Programs Biomed. 2023 Oct;240:107660. (PMID: 37320940)
Neural Netw. 2020 Nov;131:251-275. (PMID: 32829002)
Med Biol Eng Comput. 2023 May;61(5):991-1004. (PMID: 36639550)
BMC Ophthalmol. 2018 Nov 6;18(1):288. (PMID: 30400869)
IEEE Trans Image Process. 2017 Jul;26(7):3142-3155. (PMID: 28166495)
Phys Med Biol. 2023 Dec 12;68(24):. (PMID: 37934040)
Immunopharmacol Immunotoxicol. 2025 Apr;47(2):222-227. (PMID: 39885372)
Endocrinol Metab Clin North Am. 2021 Sep;50(3):431-455. (PMID: 34399955)
Micron. 2024 May;180:103615. (PMID: 38471391)
Sci Rep. 2022 Sep 2;12(1):14951. (PMID: 36056119)
Phys Med Biol. 2023 Oct 02;68(20):. (PMID: 37703894)
Inflamm Res. 2019 Apr;68(4):275-284. (PMID: 30798334)
Curr Pharm Des. 2024;30(20):1541-1547. (PMID: 38706350)
Contributed Indexing:
Keywords: Deep learning; Diabetic retinopathy; Fundus image denoising; Medical image processing; Parameterized quantum circuits (PQC); Quantum computing
Entry Date(s):
Date Created: 20260121 Date Completed: 20260212 Latest Revision: 20260215
Update Code:
20260215
PubMed Central ID:
PMC12901999
DOI:
10.1038/s41598-026-35540-3
PMID:
41565887
Database:
MEDLINE

*Further Information*

*Diabetic Retinopathy (DR) is a critical source of blindness that can be prevented globally, and accurate analysis of retinal fundus images enables early detection. Fundus images are often affected by multiple noise sources, which impair image quality and hinder the observation of delicate retinal structures, including microaneurysms and small blood vessels. Deep learning driven denoising models are computationally intensive and prone to overfitting on small medical datasets. In order to overcome these shortcomings, the present paper suggests a Quantum Denoising Autoencoder (QDAE), a hybrid quantum-classical architecture, which uses convolutional feature coding with parameterized quantum circuits (PQCs) in latent space. The suggested QDAE applies quantum superposition and entanglement to improve the latent representations, thereby improving denoising and retinal detail preservation. Experiments on the Diabetic Retinopathy 224 × 224 (2019) dataset show that QDAE performs considerably better than classical denoising architectures, including CAE, ResNet, and DnCNN with PSNR of 38.8 dB, SSIM of 0.96, and AMI of 0.88. The approach preserves delicate retinal patterns and intensity consistency, while incurring a slight computational overhead associated with shallow quantum circuits. The results presented above demonstrate that QDAE is a potential quantum-aided architecture for denoising retinal images and a feasible preprocessing procedure in early diabetic retinopathy.
(© 2026. The Author(s).)*

*Declarations. Competing interests: The authors declare no competing interests.*